Liver transplantation for patients with lamivudine-resistant HBV: What is the optimal prophylactic strategy?

被引：6

作者：

Lok, ASF ^{[1
]}

机构：

[1] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI 48109 USA

来源：

LIVER TRANSPLANTATION | 2005年 / 11卷 / 05期

关键词：

D O I：

10.1002/lt.20409

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：490 / 493

页数：4

共 26 条

[1] Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase [J].

Angus, P ;

Vaughan, R ;

Xiong, S ;

Yang, HL ;

Delaney, W ;

Gibbs, C ;

Brosgart, C ;

Colledge, D ;

Edwards, R ;

Ayres, A ;

Bartholomeusz, A ;

Locarnini, S .

GASTROENTEROLOGY, 2003, 125 (02) :292-297

[2] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].

Bartholomew, MM ;

Jansen, RW ;

Jeffers, LJ ;

Reddy, KR ;

Johnson, LC ;

Bunzendahl, H ;

Condreay, LD ;

Tzakis, AG ;

Schiff, ER ;

Brown, NA .

LANCET, 1997, 349 (9044) :20-22

[3] Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy [J].

Fontana, RJ ;

Hann, HWL ;

Perrillo, RP ;

Vierling, JM ;

Wright, T ;

Rakela, J ;

Anschuetz, G ;

Davis, R ;

Gardner, SD ;

Brown, NA .

GASTROENTEROLOGY, 2002, 123 (03) :719-727

[4] Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B [J].

Fontana, RJ ;

Keeffe, EB ;

Carey, W ;

Fried, M ;

Reddy, R ;

Kowdley, KV ;

Soldevila-Pico, C ;

McClure, LA ;

Lok, ASF .

LIVER TRANSPLANTATION, 2002, 8 (05) :433-439

[5] Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES) [J].

Hadziyannis, S ;

Tassopoulos, N ;

Chang, TT ;

Heathcote, J ;

Kitis, G ;

Rizzetto, M ;

Marcellin, P ;

Lim, SG ;

Chen, SS ;

Arterburn, S ;

Ma, J ;

Xiong, S ;

Wollman, M ;

James, C ;

Currie, G ;

Brosgart, CL .

JOURNAL OF HEPATOLOGY, 2004, 40 :17-17

[6] Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy [J].

Leung, NWY ;

Lai, CL ;

Chang, TT ;

Guan, R ;

Lee, CM ;

Ng, KY ;

Lim, SG ;

Wu, PC ;

Dent, JC ;

Edmundson, S ;

Condreay, LD ;

Chien, RN .

HEPATOLOGY, 2001, 33 (06) :1527-1532

[7] Results of lamivudine trials in Asia [J].

Liaw, YF .

JOURNAL OF HEPATOLOGY, 2003, 39 :S111-S115

[8] Long-term safety of lamivudine treatment in patients with chronic hepatitis B [J].

Lok, ASF ;

Lai, CL ;

Leung, N ;

Yao, GB ;

Cui, ZY ;

Schiff, ER ;

Dienstag, JL ;

Heathcote, EJ ;

Little, NR ;

Griffiths, DA ;

Gardner, SD ;

Castiglia, M .

GASTROENTEROLOGY, 2003, 125 (06) :1714-1722

[9] PRETRANSPLANTATION INTERFERON TREATMENT AND RECURRENCE OF HEPATITIS-B VIRUS-INFECTION AFTER LIVER-TRANSPLANTATION FOR HEPATITIS-B RELATED END-STAGE LIVER-DISEASE [J].

MARCELLIN, P ;

SAMUEL, D ;

AREIAS, J ;

LORIOT, MA ;

ARULNADEN, JL ;

GIGOU, M ;

DAVID, MF ;

BISMUTH, A ;

REYNES, M ;

BRECHOT, C ;

BENHAMOU, JP ;

BISMUTH, H .

HEPATOLOGY, 1994, 19 (01) :6-12

[10] Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants [J].

Marzano, A ;

Lampertico, P ;

Mazzaferro, V ;

Carenzi, S ;

Vigano, M ;

Romito, R ;

Pulvirenti, A ;

Franchello, A ;

Colombo, M ;

Salizzoni, M ;

Rizzetto, M .

LIVER TRANSPLANTATION, 2005, 11 (05) :532-538

← 1 2 3 →